Stay updated on Merck & Co. Press Releases
Sign up to get notified when there's something new on the Merck & Co. Press Releases page.

Latest updates to the Merck & Co. Press Releases page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded the February 28, 2026 press releases (KEYTRUDA® plus WELIREG® and WELIREG® plus LENVIMA®) and removed older February 11–12, 2026 releases from the listing.SummaryDifference6%

- Check17 days agoChange DetectedNew news releases were added on February 27, 2026 and February 25, 24, and 23, 2026. Older items from January and early February 2026 were removed.SummaryDifference6%

- Check24 days agoChange DetectedAdded two new press releases dated February 19, 2026 and February 18, 2026 to the News releases list. Removed older items dated January 5, 2026 and December 19, 2025 from the list.SummaryDifference5%

- Check32 days agoChange DetectedNew February 11 and February 12, 2026 news releases were added to the News releases page, including updates on ASCO GU data and KEYTRUDA/QLEX approvals. Two December 2025 releases were removed.SummaryDifference5%

- Check39 days agoChange DetectedTwo new news releases were added to the listing (Feb 3, 2026 financial results; Moderna–Merck data release). An older release (Dec 4, 2025 EXZOLT-related item) was removed.SummaryDifference6%

- Check46 days agoChange DetectedNew news release entry 'Merck Announces Second-Quarter 2026 Dividend' dated January 27, 2026 has been added. The older entry 'Merck Showcases Data for Alzheimer’s Disease Candidates MK-2214 and MK-1167 at CTAD 2025' has been removed.SummaryDifference6%

Stay in the know with updates to Merck & Co. Press Releases
Enter your email address, and we'll notify you when there's something new on the Merck & Co. Press Releases page.